Mark A. Goldberg - Jun 29, 2023 Form 3 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Role
Director
Signature
/s/ Daniel L. Woodard, Attorney-in-Fact
Stock symbol
INTS
Transactions as of
Jun 29, 2023
Transactions value $
$0
Form type
3
Date filed
6/29/2023, 07:56 PM
Next filing
Mar 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INTS Stock Option (right to buy Common Stock) Jun 29, 2023 Common Stock 25K $9.00 Direct F1
holding INTS Stock Option (right to buy Common Stock) Jun 29, 2023 Common Stock 7.5K $9.00 Direct F1
holding INTS Stock Option (right to buy Common Stock) Jun 29, 2023 Common Stock 5.25K $11.50 Direct F1
holding INTS Stock Option (right to buy Common Stock) Jun 29, 2023 Common Stock 25K $11.50 Direct F2
holding INTS Stock Option (right to buy Common Stock) Jun 29, 2023 Common Stock 25K $9.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable.
F2 This option is vested and exercisable with regard to 12,500 shares of Common Stock. This option will vest with regard to the remaining shares of Common Stock, subject to the individual's continued service as a director of Intensity Therapeutics, Inc., in two equal annual installments, beginning on August 13, 2023.
F3 This option is vested and exercisable with regard to 6,250 shares of Common Stock. This option will vest with regard to the remaining shares of Common Stock, subject to the individual's continued service as a director of Intensity Therapeutics, Inc., in three equal installments, beginning on December 13, 2023.

Remarks:

Exhibit 24 - Power of Attorney